129 related articles for article (PubMed ID: 9631151)
1. Long-term remission of AIDS-related primary central nervous system lymphoma associated with highly active antiretroviral therapy.
McGowan JP; Shah S
AIDS; 1998 May; 12(8):952-4. PubMed ID: 9631151
[No Abstract] [Full Text] [Related]
2. Interleukin-2, ganciclovir, and high-dose zidovudine for the treatment of AIDS-associated primary central nervous system lymphoma.
Aboulafia DM
Clin Infect Dis; 2002 Jun; 34(12):1660-2. PubMed ID: 12032910
[No Abstract] [Full Text] [Related]
3. Acquired immunodeficiency syndrome-related lymphoma: clinical aspects.
Levine AM
Semin Oncol; 2000 Aug; 27(4):442-53. PubMed ID: 10950371
[TBL] [Abstract][Full Text] [Related]
4. [AIDS associated cancers in the era of highly active antiretroviral therapy (HAART)].
Tserenpuntsag B; Kołacińska A; Jabłonowska E
Przegl Epidemiol; 2007; 61(3):529-34. PubMed ID: 18069390
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous regression of HIV associated T-cell non-Hodgkin's lymphoma with highly active antiretroviral therapy.
Fätkenheuer G; Hell K; Roers A; Diehl V; Salzberger B
Eur J Med Res; 2000 Jun; 5(6):236-40. PubMed ID: 10882638
[TBL] [Abstract][Full Text] [Related]
6. Highly active antiretroviral therapy in human herpesvirus-8-related body-cavity-based lymphoma.
Spina M; Gaidano G; Carbone A; Capello D; Tirelli U
AIDS; 1998 May; 12(8):955-6. PubMed ID: 9631153
[No Abstract] [Full Text] [Related]
7. [Cavum lymphoma in a hemophilic patient with AIDS].
Corti M; Villafañe MF; Cermelj M; Candela M; Pérez Blanco R; Tezanos Pinto M
Medicina (B Aires); 2000; 60(3):351-3. PubMed ID: 11050815
[TBL] [Abstract][Full Text] [Related]
8. High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease.
Gabarre J; Marcelin AG; Azar N; Choquet S; Lévy V; Lévy Y; Tubiana R; Charlotte F; Norol F; Calvez V; Spina M; Vernant JP; Autran B; Leblond V
Haematologica; 2004 Sep; 89(9):1100-8. PubMed ID: 15377471
[TBL] [Abstract][Full Text] [Related]
9. AIDS-related non-Hodgkin's lymphoma in the first decade of highly active antiretroviral therapy.
Palmieri C; Treibel T; Large O; Bower M
QJM; 2006 Dec; 99(12):811-26. PubMed ID: 17085516
[TBL] [Abstract][Full Text] [Related]
10. Changing pattern of primary cerebral lymphoma in the highly active antiretroviral therapy era.
Cingolani A; Fratino L; Scoppettuolo G; Antinori A
J Neurovirol; 2005; 11 Suppl 3():38-44. PubMed ID: 16540454
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment with modified CHOP-rituximab in pediatric AIDS-related advanced stage Burkitt lymphoma.
Crosswell HE; Bergsagel DJ; Yost R; Lew G
Pediatr Blood Cancer; 2008 Apr; 50(4):883-5. PubMed ID: 17278123
[TBL] [Abstract][Full Text] [Related]
12. Synchronous fibrosarcoma and medullary thyroid cancer in a man with AIDS.
Ally N; Kumar D; Wodajo FM
Am J Clin Oncol; 2006 Oct; 29(5):532-3. PubMed ID: 17023794
[No Abstract] [Full Text] [Related]
13. Severe HIV-1 encephalitis and development of cerebral non-Hodgkin lymphoma in a patient with persistent strong HIV-1 replication in the brain despite potent HAART -- case report and review of the literature.
Baeuerle M; Schmitt-Haendle M; Taubald A; Mueller S; Walter H; Pfeiffer C; Manger B; Harrer T
Eur J Med Res; 2005 Jul; 10(7):309-16. PubMed ID: 16055403
[TBL] [Abstract][Full Text] [Related]
14. Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study.
Simcock M; Blasko M; Karrer U; Bertisch B; Pless M; Blumer L; Vora S; Robinson JO; Bernasconi E; Terziroli B; Moirandat-Rytz S; Furrer H; Hirschel B; Vernazza P; Sendi P; Rickenbach M; Bucher HC; Battegay M; Koller MT;
Antivir Ther; 2007; 12(6):931-9. PubMed ID: 17926647
[TBL] [Abstract][Full Text] [Related]
15. Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival.
Diamond C; Taylor TH; Aboumrad T; Anton-Culver H
Cancer; 2006 Jan; 106(1):128-35. PubMed ID: 16329140
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic approaches to AIDS-related malignancies.
Berretta M; Cinelli R; Martellotta F; Spina M; Vaccher E; Tirelli U
Oncogene; 2003 Sep; 22(42):6646-59. PubMed ID: 14528290
[TBL] [Abstract][Full Text] [Related]
17. Remission after radiotherapy for a patient with chemotherapy-refractory HIV-associated primary effusion lymphoma.
Cassoni A; Ali U; Cave J; Edwards SG; Ramsay A; Miller RF; Lee SM
J Clin Oncol; 2008 Nov; 26(32):5297-9. PubMed ID: 18854561
[No Abstract] [Full Text] [Related]
18. AIDS-related primary CNS lymphoma: a brief review.
Taiwo BO
AIDS Read; 2000 Aug; 10(8):486-91. PubMed ID: 10967810
[TBL] [Abstract][Full Text] [Related]
19. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
Cheung MC; Pantanowitz L; Dezube BJ
Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
[TBL] [Abstract][Full Text] [Related]
20. HIV+ MALT lymphoma remission induced by highly active antiretroviral therapy alone.
Girard T; Luquet-Besson I; Baran-Marszak F; Raphaël M; Boué F
Eur J Haematol; 2005 Jan; 74(1):70-2. PubMed ID: 15613110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
